Company Search:
Advanced Search
Sponsored Links
Oncodesign Sa Company Snapshot
Oncodesign Sa operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oncodesign Sa with three other companies in this sector in France: Genoway (2017 sales of 9.86 million Euro [US$11.42 million] ), GeNeuro SA (14.95 million Euro [US$17.30 million] ), and Adocia SAS (19.47 million Euro [US$22.53 million] of which 100% was Regenerative Medicine).

Sales Analysis. During the year ended December of 2017, sales at Oncodesign Sa were 14.31 million Euro (US$16.56 million). This is an increase of 26.9% versus 2016, when the company's sales were 11.27 million Euro. Despite this increase, sales are still slightly below the level achieved in 2015, when Oncodesign Sa reported sales of 14.52 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Oncodesign Sa
  Stock Performance Chart for Oncodesign Sa
  Stock Data: Recent Stock Performance:
  Current Price (10/12/2018): 8.94
(Figures in Euro)
1 Week -7.8%   13 Weeks -15.7%  
4 Weeks -3.0%   52 Weeks -23.3%  
Oncodesign Sa Key Data:
  Ticker: ALONC Country: France
  Exchanges: PAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 14,305,000
(Year Ending Jan 2018).
Employees: 180
  Currency: Euro Market Cap: 60,801,521
  Fiscal Yr Ends: December Shares Outstanding: 6,801,065
  Share Type: Ordinary Closely Held Shares: 3,477,390
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.